Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

New Article on the Dangers of Chloramphenicol in Milk and Its Detection

Published: Tuesday, July 02, 2013
Last Updated: Tuesday, July 02, 2013
Bookmark and Share
An article exploring the dangers posed by chloramphenicol (CAP) in milk and its detection using the EVOQ Qube LC-TQ MS/MS is described.

The article entitled “The Danger of Chloramphenicol in Milk” from the Bruker Chemical & Applied Markets (CAM) division has been published in Food Safety Magazine online. Authored by Bruker specialists in liquid chromatography, the article examines the dangerous effects of CAP in contaminated food and how the high sensitivity EVOQ can detect levels as low as 0.02 ppb in milk, far exceeding minimum required performance levels (MRPL) set by EU guidelines.
Chloramphenicol is a naturally occurring broad spectrum antibiotic, initially employed as a first line of treatment for typhoid. Although CAP is still commonly prescribed as an optical treatment in the EU, its use is otherwise severely limited. This is in part due to the risk the drug poses to infants, who lack the fully developed liver enzymes to metabolize the drug. Ingestion of CAP can thus cause potentially fatal Gray Baby syndrome, and has also been linked to acute lymphotic leukemia and bone marrow suppression.
Consequently in the EU chloramphenicol is banned from use in veterinary medicine and its presence in food products such as milk is strictly prohibited. Regulations state that methods used for the detection of CAP in milk must meet or exceed the MRPL of 0.3 ppb. A case study was carried out on the EVOQ Qube LC-TQ MS/MS, designed for maximum sensitivity in high throughput applications. The EVOQ was able to quantify concentrations as low as 0.2 ppb, easily exceeding EU guidelines, while maintaining consistent ion rations from 0.05 to 1.0 ppb.
“Routine food testing requires sustained high sensitivity and the fastest possible turnaround, since time can be critical,” Meredith Conoley, Marketing Director for Bruker CAM, said. “The EVOQ was specifically designed with new technological innovations to meet these criteria. The Active Exhaust prevents the recirculation of nebulized gases to reduce chemical build up, while the Orifice Interface is continually flushed to keep it clean and reduce instrument downtime. PACER exception based data review software moreover provides the fastest sample to report time possible. This high performance instrument offers advantages for many application areas, including environmental testing and forensics.”

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,100+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Integrated Omics Analysis
Studying multi-omics promises to give a more holistic picture of the organism and its place in its ecosystem, however despite the complexities involved those within the field are optimistic.
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Structure of Primary Cannabinoid Receptor is Revealed
The findings provide key insights into how natural and synthetic cannabinoids including tetrahydrocannabinol —a primary chemical in marijuana—bind at the CB1 receptor to produce their effects.
Overlooked Molecules Could Revolutionise our Understanding of the Immune System
Researchers have discovered that around one third of all the epitopes displayed for scanning by the immune system are a type known as ‘spliced’ epitopes.
Illumina Contributes to ClinVar Database
The contribution includes variants of all classifications, from pathogenic to benign, identified during interpretation of whole genome sequences generated in the CLIA-certified, CAP-accredited Illumina Clinical Services Laboratory.
Agilent Presents Early Career Professor Award to Dr. Roeland Verhaak
JAX professor recognized for the development and implementation of workflows for the analysis of big-data from transcriptomics to next generation sequencing approaches.
NIH Study Determines Key Differences between Allergic and Non-Allergic Dust Mite Proteins
Researchers at NIH have uncovered factors that lead to the development of dust mite allergy and assist in the design of better allergy therapies.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos